Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Value of Conization and Negative HPV Typing After Conization Prior to Surgical Intervention in Adenocarcinoma in Situ and Early Stage Cervical Cancer

NCT06196190 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT06196190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06196190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Value of Conization and Negative HPV Typing After Conization Prior to Surgical Intervention in Adenocarcinoma in Situ and Early Stage Cervical Cancer
Lead sponsor
Rambam Health Care Campus
Phase
Observational
Overall status
Recruiting
Start date
July 26, 2023
Completion date
July 1, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervix cancer, hpv-related malignancy